Interestingly, three NOX2 subunits (CYBB, NCF2 and NCF4) are among a set of 311 genes which we recently identified as being consistently downregulated in the bone marrow (BM) of AML patients from various cytogenetic subgroups, compared to healthy controls [57]. This evidence concerns the gene NCF2 and acute myeloid leukemia.